Welcome to the e-CCO Library!

P520: Gastrointestinal ultrasonography in pregnant patients with IBD is useful in the identification of active intestinal inflammation
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Flanagan1, E. Wright1, J. Begun2,3, R. Bryant4,5, D. Sathananthan4, S. Bell1*

Created: Thursday, 21 February 2019, 9:14 AM
P520: Perspective and self-efficacy of adolescents with inflammatory bowel disease post transition to adult care
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Yadav A., Forry M., O'Toole A., Patchett S.

Created: Wednesday, 20 February 2019, 10:36 AM
P520: Thromboembolic and major adverse cardiovascular events among patients in the filgotinib clinical trial programme
Year: 2023
Source: ECCO’23 Copenhagen
Authors: van der Woude, J.(1)*;Schreiber , S.(2);Peyrin-Biroulet , L.(3);Szekanecz, Z.(4);Choy, E.H.(5);Stiers, P.J.(6);Van Hoek, P.(7);Van Beneden, K.(8);de Haas, A.(9);Rudolph , C.(10);ten Cate, H.(11);
Created: Friday, 14 July 2023, 11:05 AM
P520: Very early intestinal ultrasound predicts intravenous corticosteroid failure in hospitalized severe ulcerative colitis patients
Year: 2022
Source: ECCO'22
Authors: Fremberg Ilvemark, J.(1);Wilkens, R.(2);Thielsen, P.(1);Kirch Dige, A.(3);Boysen, T.(2);Brynskov, J.(1);Tveiten Bjerrum, J.(1);Seidelin, J.(1);
Created: Friday, 11 February 2022, 3:56 PM
P520: ‘Eetscore’ in patients with Inflammatory Bowel Disease: an online tool to assess diet quality and provide personalised dietary advice
Year: 2021
Source: ECCO'21 Virtual
Authors: Lamers, C.R.(1,2);van Erp, L.W.(3);Slotegraaf, A.I.(2);Groenen, M.J.M.(3);de Roos, N.M.(2);Wahab, P.J.(3);Witteman, B.J.M.(1,2);
Created: Wednesday, 2 June 2021, 4:12 PM
P521 Infection of the anal canal by human papillomavirus in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. Guzela1, C. Sobrado Júnior1, S. Nadal2, C.R. Nadal2, L.L. Villa3, A.P. Gonçalves1, L.R. Boarini1, S.C. Nahas1, I. Cecconello1

Created: Thursday, 30 January 2020, 10:12 AM
P521: A prospective cohort study to assess the relevance of Vedolizumab drug level monitoring in IBD patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Schulze H.*1, Esters P.1, Hartmann F.1, Stein J.2, Christ C.3, Zorn M.3, Dignass A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P521: Correlation between physician disease assessment in Ulcerative Colitis and burden of disease: ICONIC 2-year data of 120 patients in Turkey
Year: 2021
Source: ECCO'21 Virtual
Authors: Sezgin, O.(1);Atug, O.(2);Gonen, C.(3);Can, G.(4);Duman, A.E.(5);Erzin, Y.Z.(6);Yurci, M.A.(7);Alkim, C.(8);Unal Ozcelik, N.G.(9);Yildirim, B.(10);Kayacetin, E.(11);Beyazit, Y.(12);Tayfur Yurekli, O.(11);Kiyici, M.(13);
Created: Wednesday, 2 June 2021, 4:12 PM
P521: Correlation of histological assessment of mucosal healing with long-term clinical and patient-reported outcomes in patients with moderately to severely active ulcerative colitis treated with upadacitinib: results from the Phase 3 U-ACHIEVE maintenance trial
Year: 2022
Source: ECCO'22
Authors: Parkes, G.(1);Ungaro, R.(2);Danese, S.(3);Abreu, M.(4);Arenson, E.(5);Zhou, W.(6);Ilo, D.(6);Laroux, F.S.(7);Deng, H.(8);Sanchez Gonzalez, Y.(6);Peyrin-Biroulet, L.(9);
Created: Friday, 11 February 2022, 3:56 PM
P521: Effectiveness of ustekinumab as therapy for chronic antibiotic refractory pouchitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Outtier, A.(1)*;Louis, E.(2);Dewit, O.(3);Schops, G.(1);Verstockt, B.(1);Sabino, J.(1);Vermeire, S.(1);Ferrante, M.(1);
Created: Friday, 14 July 2023, 11:05 AM
P521: Evaluation of adalimumab effectiveness in paediatric patients with ulcerative colitis in clinical practice
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Steiner1*, C. Liu2, E. King2, E. Israel3, B. Pasternak4, M. Schaefer5, S. Chen2, J. Pratt2, A. Lazar6, M. Bereswill6, A. Robinson7, R. Colletti8, ImproveCareNow Network9

Created: Thursday, 21 February 2019, 9:14 AM
P521: Pre-operative enteral nutrition in adults with Crohn’s disease: effect on gut microbiota and disease outcomes
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. P. Costa Santos*1, C. Palmela1, J. Torres1, A. Ferreira1, S. Velho1, L. Glória1, S. Ouro1, I. Gordo2, M. Cravo1

Created: Friday, 22 February 2019, 9:41 AM
P522 Prior pharmacotherapy patterns among patients with IBD in the USA initiating biologic therapy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Bornheimer1, S. Hass2, A. NAG3, G. Oster1

Created: Thursday, 30 January 2020, 10:12 AM
P522: A multicenter study to validate Magnetic Resonance Enterography against histological assessments of stenotic disease in patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Coimbra A.*1, Rimola J.2, Cuatrecasas M.2, De Hertogh G.3, Van Assche G.3, Vanslembrouck R.3, Glerup H.4, Hedemann Nielsen A.4, Hagemann-Madsen R.4, Bouhnik Y.5, Zappa M.5, Cazals-Hatem D.5, D'Haens G.6, Stoker J.6, Meijer S.6, Rogler G.7, Boss A.7, Weber A.7, Zhao R.1, Keir M.1, Scherl A.1, deCrespigny A.1, Lu T.1, Panes J.2

Created: Wednesday, 20 February 2019, 10:36 AM
P522: Effectiveness of tofacitinib in a real-world Israeli cohort of patients with moderate-severe ulcerative colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Avni Biron, I.(1);Bar-Gil Shitrit , A.(2);Koslowsky, B.(2);Kopylov, U.(3);Levartovsky, A.(3);Weisshof, R.(4);Aviv-Cohen, N.(5);Maharshak, N.(5);Hovel, D.(6);Naftali, T.(7);Goren, I.(1);Snir, I.(1);ollech, J.(1);Banai, H.(1);Lena, B.(1);Dotan, I.(1);Yanai, H.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P522: Expression of markers of early atherosclerosis in inflammatory bowel disease: a prospective cohort of a single referral centre
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Scrivo*1, M. G. Cilluffo1, A. Tuttolomondo2, D. Torres2, V. Calvaruso1, A. Pinto2, M. Cappello3

Created: Friday, 22 February 2019, 9:41 AM
P522: Kono-S anastomosis reduces endoscopic and surgical post-operative recurrence in Crohn's disease. The SuPREMe-CD Trial Update.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Luglio, G.(1)*;Rispo, A.(2);Tropeano, F.P.(3);Giglio, M.C.(4);Cricrì, M.(4);Imperatore, N.(5);De Sire, R.(4);Guarino, A.D.(4);Bucci, L.(6);Castiglione, F.(4);De Palma, G.D.(4);
Created: Friday, 14 July 2023, 11:05 AM
P522: Soluble sMadCAM1 and retinoic acid are potential tools for therapeutic drug monitoring in inflammatory bowel disease s under vedolizumab: A proof of concept
Year: 2018
Source: ECCO '18 Vienna
Authors:

X. Roblin1*, N. Williet1, G. Boschetti2, B. Flourie2, E. Del Tedesco3, L. Peyrin Biroulet4, J.m. Phelip3, S. Nancey2, S. Paul5

Created: Thursday, 21 February 2019, 9:14 AM
P522: Upadacitinib Promotes Histologic and Endoscopic Mucosal Healing: Results from the Upadacitinib Ulcerative Colitis Phase 3 Program
Year: 2022
Source: ECCO'22
Authors: Peyrin-Biroulet, L.(1);Siegel, C.(2);Tanida, S.(3);Bossuyt, P.(4);Torres, E.(5);Dubinsky, M.(6);Baert, F.(7);Zhou, W.(8);Klaff, J.(8);Berg, S.(8);Laroux, F.S.(9);Sanchez Gonzalez, Y.(8);Yao, X.(8);Zhou, Q.(8);Reinisch, W.(10);
Created: Friday, 11 February 2022, 3:56 PM
P523 Improvement of quality of life and continence in patients with distal ulcerative colitis treated by mesalazine: QUARTZ study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

T. Paupard1, F. Gonzalez2, L. Siproudhis3, L. Peyrin-Biroulet4, Thierry Paupard

Created: Thursday, 30 January 2020, 10:12 AM